Advertisement

Topics

Pancreatic BetaCell Protection Hot Targets Pipeline Analysis [Report Updated: 12082016] Prices from USD $3600

12:56 EDT 18 Aug 2017 | BioPortfolio Report Blog

Pancreatic Betacell Protection Hot Targets Pipeline Analysis gives comprehensive insight on the various drugs being developed for the treatment of Pancreatic Betacell protection. The report covers hot targets molecules in research for betacell protection in both Type1 diabetes Type2 diabetes disease progression.
This report enables Pharmaceutical /Biotech companies, Academic institutes, Individual researchers, Investors, Medical technology companies, Service providers and other associated stake holders to identify and analyze the available licensing/collaborative commercial opportunities in the Diabetes Drug market. The report also provides strategic insights on medicines that are likely to have an impact on betacell protection treatment space and potentially alter standards of care in the foreseeable future.
Therapies that are presently available for diabetes focus on reducing the disease symptoms, but there is a huge unmet need for therapies that can either slow or prevent the beta cell loss as there is a rapid loss of cells in type 1 diabetes and progressive loss in type 2 diabetes patients
Currently, researchers are focusing on novel therapeutic strategies aimed at restoring, or at least preventing further loss of beta cell mass in beta cell deficit type 1 and type 2 diabetes patients as endogenous secretion of insulin is advantageous over exogenous insulin such as direct effect on hepatic liver glucose metabolism. Hence, it provides a tremendous opportunity for upcoming therapies specific to Betacell loss such as MAbs, stem cellbased, gene therapies and RNAbased therapies. These modalities may provide betacell protection, regeneration, mass increase with additional benefits of weight loss, triglyceride lowering and kidney protection.

Original Article: Pancreatic BetaCell Protection Hot Targets Pipeline Analysis [Report Updated: 12082016] Prices from USD $3600

NEXT ARTICLE

More From BioPortfolio on "Pancreatic BetaCell Protection Hot Targets Pipeline Analysis [Report Updated: 12082016] Prices from USD $3600"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pancreatic Cancer
The pancreas secretes a number of important hormones into the digestive tract and the blood stream. Cancers are most commonly exocrine than endocrine (neuroendocrine) tumors. Functional tumors secrete hormones; Insulinoma, Gastrinoma, Somatostatinoma, VI...

Pancreatitis
Pancreatitis Acute pancreatitis is inflammation of the pancreas caused by the release of activated pancreatic enzymes. Common triggers are biliary tract disease and chronic heavy alcohol intake.  Diagnosis is based on clinical presentation...